Synergy CHC Corp. (Uplisting) (NASDAQ:SNYR) Upgraded at Roth Capital

Synergy CHC Corp. (Uplisting) (NASDAQ:SNYR) was upgraded by stock analysts at Roth Capital to a “strong-buy” rating in a research report issued on Tuesday,Zacks.com reports.

Separately, Roth Mkm assumed coverage on shares of Synergy CHC Corp. (Uplisting) in a report on Tuesday. They set a “buy” rating and a $10.00 target price on the stock.

Synergy CHC Corp. (Uplisting) Trading Down 0.2 %

SNYR opened at $4.06 on Tuesday. The business’s 50-day moving average price is $5.15. Synergy CHC Corp. has a 12-month low of $0.12 and a 12-month high of $10.00.

Synergy CHC Corp. (Uplisting) (NASDAQ:SNYR) last issued its quarterly earnings results on Friday, December 6th. The company reported $0.10 earnings per share (EPS) for the quarter.

Insider Buying and Selling

In other news, CEO Jack Ross bought 300,000 shares of Synergy CHC Corp. (Uplisting) stock in a transaction that occurred on Thursday, October 24th. The shares were purchased at an average price of $9.00 per share, with a total value of $2,700,000.00. Following the completion of the acquisition, the chief executive officer now directly owns 300,000 shares in the company, valued at $2,700,000. The trade was a ∞ increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.

Synergy CHC Corp. (Uplisting) Company Profile

Synergy CHC Corp. engages in the marketing and distribution of branded health and wellness products. The company was founded on December 29, 2010 and is headquartered in Westbrook, ME.